Healthcare -
Biotechnology - NASDAQ - US
$ 31.23
0.872 %
$ 12 B
Market Cap
-3.37
P/E
Price Target
Average
285.12%
Revenue Forecast
Estimate
25.17%
EBIT
Estimate
14.43%
Net Income
Estimate
20.93%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Moderna, Inc.
Wall Street analysts predict an average 1-year price target for MRNA of $120 , with forecasts ranging from
a
low of
$45 to a high of $310 .
MRNA Lowest Price Target
Wall Street Target
45 USD
44.09%
MRNA Average Price Target
Wall Street Target
120 USD
285.12%
MRNA Highest Price Target
Wall Street Target
310 USD
892.64%
REVENUE FORECAST
Revenue Forecast Chart MRNA
EBIT FORECAST
EBIT Forecast Chart MRNA
NET INCOME FORECAST
Net Income Chart MRNA